Astria Therapeutics licenses navenibart rights to Kaken for HAE
Astria Therapeutics has entered an exclusive licensing agreement with Kaken Pharmaceutical for the development and commercialisation rights of navenibart in…
Dermatology
-
-
J&J seeks FDA approval for icotrokinra to treat psoriasis
Johnson & Johnson (J&J) has submitted a new drug application (NDA) seeking approval from the US Food and Drug Administration…
-
LEO Pharma secures rights to Boehringer’s Spevigo for $105m
Danish dermatology leader LEO Pharma has bought the rights to Boehringer Ingelheim’s psoriasis drug Spevigo (spesolimab) for €90m ($105m), strengthening…
-
FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid
The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults…
-
‘Dupixent-fuelled’ atopic dermatitis market sales to hit $22.4bn by 2033
The global atopic dermatitis (AD) market is poised to reach $22.4bn in drug sales within the decade, buoyed by the…
-
Ascletis’s daily acne tablet set for China review after Phase III win
Sagimet Bioscience’s denifanstat, a one-daily pill for the treatment of acne, has succeeded in a Phase III trial, with the…
-
Eligo Bioscience secures grant to advance topical gene delivery platform
Biotechnology company Eligo Bioscience has obtained a $5m grant from the French Government to expedite the development and upscaling of…
-
Sanofi and Regeneron’s dupilumab approved by FDA for urticaria
Sanofi and Regeneron's fully human monoclonal antibody Dupixent (dupilumab) has gained approval from the US Food and Drug Administration (FDA)…
-
Alumis and Kaken sign agreement in Japan to develop ESK-001
Alumis and Kaken Pharmaceutical have entered a partnership and licensing agreement for the development, manufacture and commercialisation of the former’s…
-
Menarini to enhance BPDCN detection with VisualDx’s link
The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the detection of…
